Dr. John M. Clark, D.O.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
100 E Lancaster Ave, Heart Pavilion Mezzanine Level
Wynnewood, PA 19096
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 439
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Philadelphia College of Osteopathic Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
PA license OS019297 -
Cardiovascular Disease Physician
PA license OS019297 -
Internal Medicine Physician
PA license OS019297
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Main Line Hospital Lankenau Wynnewood, PA
- Paoli Hospital Paoli, PA
- Bryn Mawr Hospital Bryn Mawr, PA
- Riddle Memorial Hospital Media, PA
Medical groups
- Main Line Healthcare (1,184 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 439
- Services billed
- 1,811
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 451 | 115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 431 | 254 |
| Established patient office or other outpatient visit, 30-39 minutes | 239 | 170 |
| Established patient office or other outpatient visit, 40-54 minutes | 203 | 160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | 133 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 102 | 85 |
| Critical care, first 30-74 minutes | 56 | 27 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 52 | 37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | 22 |
| New patient office or other outpatient visit, 60-74 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Wynnewood, PA | 309 |
| Atorvastatin Calcium Other prescribers in Wynnewood, PA | 275 |
| Entresto (sacubitril/valsartan) Other prescribers in Wynnewood, PA | 257 |
| Jardiance (empagliflozin) Other prescribers in Wynnewood, PA | 246 |
| Spironolactone Other prescribers in Wynnewood, PA | 231 |
| Torsemide Other prescribers in Wynnewood, PA | 212 |
| Furosemide Other prescribers in Wynnewood, PA | 177 |
| Eliquis (apixaban) Other prescribers in Wynnewood, PA | 164 |
| Vyndamax (tafamidis) | 157 |
| Carvedilol Other prescribers in Wynnewood, PA | 138 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $37.39 in total to this clinician.
| Medline Industries LP | $22.75 |
|---|---|
| Amgen Inc. | $14.64 |
| Food and Beverage | $37.39 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $228,566 in research payments for these studies, mostly to the institutions running them.
- ALT-FLOW II 2022-06
Edwards Lifesciences Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.